Article
Aspartate-β-hydroxylase as a promising prognostic and therapeutic biomarker for HBV-positive hepatocellular carcinoma
2023-06-05
Abstract excerpt
BACKGROUND: Hepatitis B virus (HBV) is a key factor in the development of hepatocellular carcinoma (HCC). However, effective treatments to improve prognosis are still lacking. Aspartate plays a critical role not only in tumor cell proliferation, invasion, and migration, but also in the tumor immune microenvironment. A deeper understanding of the cellular and molecular mechanisms of HBV-positive HCC in terms of the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e5171011-e5b6-5b1f-8cff-6a15411f6d32
- DOI
- 10.21203/rs.3.rs-2984696/v1
